MedPath

Development and evaluation of an online platform for advanced cancer patients who obtain durable response to immunotherapy or targeted therapy in co-creation with patients, psychologists and service providers.

Recruiting
Conditions
10001302
distress symptoms
Psychological distress
Registration Number
NL-OMON56652
Lead Sponsor
niversiteit van Tilburg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
57
Inclusion Criteria

Patients are diagnosed with stage IV cancer with confirmed response to or
long-term stable disease while on immunotherapy or targeted therapy.
We consider a response confirmed after the second scan shows that patients
respond well (i.e. RECIST at least partial response or >1 year of stable
disease) to one of both therapies.

Exclusion Criteria

- <18 years of age;
- not able to sufficiently use and understand the Dutch language;
- have no internet access.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath